Platinum group metals (PGM) mining company Valterra Platinum has received board approval to conduct a feasibility study into ...

Q2 2025 Earnings Call Transcript July 30, 2025 Altria Group, Inc. beats earnings expectations. Reported EPS is $1.44, ...

PainChek, EMVision and Clever Culture Systems are among ASX health companies reporting quarterly results today.

Alterity’s cash position on 30 June 2025 was A$40.66M with operating cash outflows for the quarter of A$2.35M. In accordance with ASX Listing Rule 4.7C, payments of A$119k made to related parties and ...

Q2 2025 Earnings Call Transcript July 29, 2025 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is ...

Tour de France 2025's extreme course design sparks debate—has the race gone too far? Read why the Tour is losing balance and ...

Mind Medicine is perhaps the best positioned stock in the psychedelics space, but it is important to remember that the whole ...

Researchers have found in a 3-year phase 3 trial that palopegteriparatide (TransCon PTH) showed sustained improvements in ...

A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.

ARC Resources is poised for further growth and will benefit when oil and gas return to favor. Click here to read an analysis ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...

But to truly succeed, First Steps must follow the lead set by these great Marvel Comics starring the Fantastic Four. Many ...